Interleukin 17A genetic variations and susceptibility to non‐small cell lung cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-0463|123|3|194-198

ISSN： 0903-4641

Source： APMIS (ELECTRONIC), Vol.123, Iss.3, 2015-03, pp. : 194-198

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inflammation‐Related Genetic Variations and Survival in Patients With Advanced Non–Small Cell Lung Cancer Receiving First‐Line Chemotherapy

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 3, 2014-09 ,pp. : 360-369

John Wiley & Sons Inc

Access to resources Recommend Favorite

Docetaxel in non-small cell lung cancer

By Souquet Pierre-Jean   Geriniere Laurence  

Therapy, Vol. 3, Iss. 5, 2006-09 ,pp. : 579-590

Future Medicine

Access to resources Recommend Favorite

Ifosfamide in Non-Small Cell Lung Cancer

By  

Oncology, Vol. 65, Iss. 2, 2003-11 ,pp. : 50-54

Karger

Access to resources Recommend Favorite

The Influence of Sex in Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 32, Iss. 10, 2009-09 ,pp. : 547-548

Karger

Access to resources Recommend Favorite

Gallbladder Metastasis of Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 27, Iss. 4, 2004-09 ,pp. : 398-400

Karger

Access to resources Recommend Favorite